Vitrafy Life Sciences Limited (ASX:VFY)
2.550
+0.250 (10.87%)
Nov 16, 2026, 4:10 PM AEDT
Vitrafy Life Sciences Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Vitrafy Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $5.09. The average 1-year stock price forecast is 99.76% higher than the current stock price, while the lowest is $4.96 (+94.67%) and the highest is $5.18 (+103.18%).
Price Target: $5.09 (+99.76%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vitrafy Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $5.06 | Buy | Maintains | $5.06 | +98.43% | Nov 2, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $5.15 → $4.85 | Buy | Maintains | $5.15 → $4.85 | +90.20% | Oct 29, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $4.20 → $5.00 | Buy | Maintains | $4.20 → $5.00 | +96.08% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
123.71K
from 209.00K
Decreased by -40.81%
Revenue Next Year
502.85K
from 123.71K
Increased by 306.47%
EPS This Year
-0.02
from -0.01
EPS Next Year
-0.02
from -0.02
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.